Your browser doesn't support javascript.
loading
Testing a longitudinal compensation model in premanifest Huntington's disease.
Gregory, Sarah; Long, Jeffrey D; Klöppel, Stefan; Razi, Adeel; Scheller, Elisa; Minkova, Lora; Johnson, Eileanoir B; Durr, Alexandra; Roos, Raymund A C; Leavitt, Blair R; Mills, James A; Stout, Julie C; Scahill, Rachael I; Tabrizi, Sarah J; Rees, Geraint.
  • Gregory S; Huntington's disease Research Centre, UCL Institute of Neurology, University College London, London, UK.
  • Long JD; Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, UK.
  • Klöppel S; Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa, City, IA, USA.
  • Razi A; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
  • Scheller E; University Hospital for Old Age Psychiatry, Murtenstrasse 21, 3010 Bern, Switzerland.
  • Minkova L; Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Freiburg, Germany.
  • Johnson EB; Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, UK.
  • Durr A; Department of Electronic Engineering, N.E.D University of Engineering and Technology, Karachi, Pakistan.
  • Roos RAC; Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Freiburg, Germany.
  • Leavitt BR; Freiburg Brain Imaging Division, Medical Center, University of Freiburg, Freiburg, Germany.
  • Mills JA; Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Freiburg, Germany.
  • Stout JC; Freiburg Brain Imaging Division, Medical Center, University of Freiburg, Freiburg, Germany.
  • Scahill RI; Huntington's disease Research Centre, UCL Institute of Neurology, University College London, London, UK.
  • Tabrizi SJ; Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK.
  • Rees G; ICM - Institut du Cerveau et de la Moelle Epinière, INSERM U1127, CNRS UMR7225, Sorbonne Universités - UPMC Université Paris VI UMR_S1127and APHP, Genetic department, Pitié-Salpêtrière University Hospital, Paris, France.
Brain ; 141(7): 2156-2166, 2018 07 01.
Article en En | MEDLINE | ID: mdl-29788038
ABSTRACT
The initial stages of neurodegeneration are commonly marked by normal levels of cognitive and motor performance despite the presence of structural brain pathology. Compensation is widely assumed to account for this preserved behaviour, but despite the apparent simplicity of such a concept, it has proven incredibly difficult to demonstrate such a phenomenon and distinguish it from disease-related pathology. Recently, we developed a model of compensation whereby brain activation, behaviour and pathology, components key to understanding compensation, have specific longitudinal trajectories over three phases of progression. Here, we empirically validate our explicit mathematical model by testing for the presence of compensation over time in neurodegeneration. Huntington's disease is an ideal model for examining longitudinal compensation in neurodegeneration as it is both monogenic and fully penetrant, so disease progression and potential compensation can be monitored many years prior to diagnosis. We defined our conditions for compensation as non-linear longitudinal trajectories of brain activity and performance in the presence of linear neuronal degeneration and applied our model of compensation to a large longitudinal cohort of premanifest and early-stage Huntington's disease patients from the multisite Track-On HD study. Focusing on cognitive and motor networks, we integrated progressive volume loss, task and resting state functional MRI and cognitive and motor behaviour across three sequential phases of neurodegenerative disease progression, adjusted for genetic disease load. Multivariate linear mixed models were fitted and trajectories for each variable tested. Our conceptualization of compensation was partially realized across certain motor and cognitive networks at differing levels. We found several significant network trends that were more complex than that hypothesized in our model. These trends suggest changes to our theoretical model where the network effects are delayed relative to performance effects. There was evidence of compensation primarily in the prefrontal component of the cognitive network, with increased effective connectivity between the left and right dorsolateral prefrontal cortex. Having developed an operational model for the explicit testing of longitudinal compensation in neurodegeneration, it appears that general patterns of our framework are consistent with the empirical data. With the proposed modifications, our operational model of compensation can be used to test for both cross-sectional and longitudinal compensation in neurodegenerative disease with similar patterns to Huntington's disease.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mapeo Encefálico / Enfermedad de Huntington Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mapeo Encefálico / Enfermedad de Huntington Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article